99.89% Pharmaceutical Raw Material Imiquimod With Fast Delivery,Imiquimod White Powder
10G
MOQ
Negotiate
Price
99.89% Pharmaceutical Raw Material Imiquimod With Fast Delivery,Imiquimod White Powder
Features Gallery Product Description Request A Quote
Features
Basic Infomation
Place of Origin: Wuhan,Hubei
Brand Name: Yuancheng
Certification: ISO9001
Model Number: 99011-02-6
High Light:

medicine raw material

,

raw material pharmaceutical

Payment & Shipping Terms
Packaging Details: Discreet packaging
Delivery Time: 4-7 working days
Payment Terms: T/T, , MoneyGram,Bitcoin
Supply Ability: 5000KG/Month
Specifications
Name: Imiquimod
CAS: 99011-02-6
Molecular Formula: C14H16N4
Formula Weight: 240.3
Appearance: White Powder
Purity: 99.89%
Product Description

99.89% Pharmaceutical Raw Material Imiquimod With Fast Delivery

Chemical Name:Imiquimod
Molecular Formula:C14H16N4
Formula Weight: 240.3
CAS No.:99011-02-6
Appearance:white powder
Purity:99.89%

 

Product description:

Imiquimod is belonging to the drug for the treatment of genital warts. Clinically it can be used as the immunomodulators in the treatment of adult genital and perianal warts with convenient application, well tolerance and unique mechanism of action which makes it be the first-choice drug for treatment of genital warts.

In addition, there are reports that imiquimod can be used for treating viral skin diseases including common warts, flat warts, molluscum and herpes simplex virus. It can also be effective in treating basal cell carcinoma, Bowen's disease, Bowen papulosis, actinic keratosis, and skin tumors such as cutaneous T-cell tumor and Kaposi's sarcoma. It may also be effective in treating vitiligo and alopecia areata.

Genital wart is the infective diseases of the human virus (HPV) infection and is a major public health threat. Currently, the infection of the genital wart in the United States is the most common viral infective sexually transmitted diseases and one of the most common sexually transmitted diseases. The infections mostly occur in sexually active people, especially for people of 20 to 24 year-olds and women in pregnancy, and prone to happen at the warm and most mucosal sites of body. Application of immunosuppressive agents or infection with the patients of human immunodeficiency

 

Product Application:

It can be used for the treatment of adult external genital and perianal genital warts at 3 times per week. Just before sleep, first apply the product evenly in a thin layer on the surface of the wart and gently massage until the product is completely absorbed.

The position of the medication should not be packeted and should be maintained for 6 to 10 hours, and then wash with a neutral soap and clean water for clearing the drugs in the administration site. Wash your hands before and after treatment.

250 mg of cream can be applied to 20cm2 of wart. Avoid excessive application of the drug. Patients should continue the treatment until the wart is completely cleared. Wart can be cleared within 2-4 week at the fastest speed and can be generally cleared within 8 to 12 weeks. The medication should be not more than 16 weeks.

After the treatment, patients with mild erythema locally who does not have to be discontinued for drug; if the patients feel general malaise or get local skin reactions (edema, erosion, pain, etc.), the drug should be discontinued. Only when the reaction is alleviated can they continue the medication.

 

The COA of Imiquimod:

 

 

Product name

 

 

Imiquimod

 

CAS No.

99011-02-6

 

Outer Packing

 

1KG

 

Production date

2016.12.23

 

Shelf life

2018.12.22

 

Standard adopted

 

 

Enterprise Standard

 

Items of analysis

 

Specification

 

Results

 

 

Appearance

 

 

Off-white powder,dissolve in hydrochloric

 

 

conform

 

Melting point

 

 

 

 

297-299℃

 

 

298.2-298.7℃

 

Identification

 

 

IR UV/HPLC

conform

 

Assay

 

 

98-101%

 

 

99.89%

 

 

 

Purity

 

 

≥99%

 

 

 

99.87%

 

 

 

Related substance

 

 

≤0.1%

 

 

0.13%

 

 

Heavy Metals

 

≤10ppm

 

 

conform

 

Loss on Drying

 

 

≤0.5%

 

≤0.5%

 

 

Residue on ignition

 

 

≤0.2%

 

 

0.02%

 

Conclusion

 

Qualified

 

 

99.89% Pharmaceutical Raw Material Imiquimod With Fast Delivery,Imiquimod White Powder 0

 

If you ara interested in Imiquimod ,plesee contact:
nancypeng@ycphar.com
skype:steroidsbio
whatsApp:86-15372437208

Recommended Products
Get in touch with us
Contact Person : Lisa
Fax : 86-27-88508150-803
Characters Remaining(20/3000)